
NEW: Emily Gibbons, Gilead Sciences, speaks with
@MorrisonCSIS about the lenacapavir partnership and what it will take to reach meaningful scale to drive HIV infections down, especially among the most vulnerable populations.
Listen here: csis.org/podcasts/commo…
English


